158 related articles for article (PubMed ID: 6110090)
1. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group.
Nesbit ME; Sather HN; Robison LL; Ortega J; Littman PS; D'Angio GJ; Hammond GD
Lancet; 1981 Feb; 1(8218):461-6. PubMed ID: 6110090
[TBL] [Abstract][Full Text] [Related]
2. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
[TBL] [Abstract][Full Text] [Related]
3. Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia.
Muriel FS; Svarch E; Pavlovsky S; Eppinger-Helft M; Braier J; Vergara B; Garay G; Kvicala R; Divito JM; Failace R; Dibar E; Jimenez E
Blood; 1983 Aug; 62(2):241-50. PubMed ID: 6575836
[TBL] [Abstract][Full Text] [Related]
4. Effect of isolated central nervous system leukaemia on bone marrow remission and survival in childhood acute lymphoblastic leukaemia. A report for Children's Cancer Study Group.
Lancet; 1981 Jun; 1(8235):1386-9. PubMed ID: 6113351
[TBL] [Abstract][Full Text] [Related]
5. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
Pinkerton CR; Chessells JM
Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
[TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group.
Ortega JA; Nesbit ME; Sather HN; Robison LL; D'Angio GJ; Hammond GD
J Clin Oncol; 1987 Oct; 5(10):1646-54. PubMed ID: 3309198
[TBL] [Abstract][Full Text] [Related]
7. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.
Sullivan MP; Chen T; Dyment PG; Hvizdala E; Steuber CP
Blood; 1982 Oct; 60(4):948-58. PubMed ID: 6956376
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).
Littman P; Coccia P; Bleyer WA; Lukens J; Siegel S; Miller D; Sather H; Hammond D
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1443-9. PubMed ID: 3305443
[TBL] [Abstract][Full Text] [Related]
9. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
Bleyer WA; Coccia PF; Sather HN; Level C; Lukens J; Niebrugge DJ; Siegel S; Littman PS; Leikin SL; Miller DR
J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
[TBL] [Abstract][Full Text] [Related]
10. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
11. CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group study.
Komp DM; Fernandez CH; Falletta JM; Ragab AH; Humphrey GB; Pullen J; Moon T; Shuster J
Cancer; 1982 Sep; 50(6):1031-6. PubMed ID: 7049344
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children.
Freeman AI; Weinberg V; Brecher ML; Jones B; Glicksman AS; Sinks LF; Weil M; Pleuss H; Hananian J; Burgert EO; Gilchrist GS; Necheles T; Harris M; Kung F; Patterson RB; Maurer H; Leventhal B; Chevalier L; Forman E; Holland JF
N Engl J Med; 1983 Mar; 308(9):477-84. PubMed ID: 6571946
[TBL] [Abstract][Full Text] [Related]
13. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
[TBL] [Abstract][Full Text] [Related]
14. CNS prophylaxis using a triple intrathecal drug therapy without cranial irradiation in acute lymphoblastic leukaemia.
Asfour I; Misset JL; Mathe G; Sabbour MS
Int J Clin Pharmacol Res; 1988; 8(1):47-54. PubMed ID: 3163327
[TBL] [Abstract][Full Text] [Related]
15. The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia.
George SL; Ochs JJ; Mauer AM; Simone JV
J Clin Oncol; 1985 Jun; 3(6):776-81. PubMed ID: 3891922
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute lymphoblastic leukaemia: effect of "prophylactic" therapy against central nervous system leukaemia. Report ot the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1973 May; 2(5863):381-4. PubMed ID: 4574042
[TBL] [Abstract][Full Text] [Related]
17. [Central nervous system irradiation for children with leukemia].
Chatani M; Teshimá T; Inoue T; Azuma I; Kumano M; Hishikawa Y; Kondo K; Tabata S; Suyama T; Yabumoto E
Gan No Rinsho; 1984 Feb; 30(2):152-6. PubMed ID: 6423857
[TBL] [Abstract][Full Text] [Related]
18. Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy.
Steinherz P; Jereb B; Galicich J
J Clin Oncol; 1985 Sep; 3(9):1217-26. PubMed ID: 3861774
[TBL] [Abstract][Full Text] [Related]
19. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1993 Mar; 11(3):520-6. PubMed ID: 8445427
[TBL] [Abstract][Full Text] [Related]
20. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
